Chemours posts Q2 2026 earnings miss and repays €230 million loan

Chemours (NYSE:CC) announced its second‑quarter 2026 financial results, reporting earnings per share of $0.42, missing the consensus estimate of $0.50. Net loss attributable to the company was $274 million, or $1.81 per diluted share, while adjusted net income came in at $64 million, or $0.42 per diluted share. Free cash flow rose 128 % year‑over‑year, and net leverage improved to 4.4 times, moving the company toward its target of sub‑3 times leverage.

The company also disclosed that it has paid down a €230 million loan, with second‑quarter cash flow reaching $114 million. Chemours announced a global TiO₂ price increase effective June 1, 2026, contributing to an approximate 5 % year‑to‑date price rise in net sales. President and CEO Denise Dignam highlighted progress on pricing actions, growth in high‑value specialty products for data‑center and semiconductor markets, and continued efforts to strengthen the balance sheet and resolve legacy litigation.